Skip to NavigationSkip to content

Medical Affairs 2025 – Excellence in the era of precision medicine

Published on 15/05/19 at 08:00am
Image Credit: stormotion.io

Medical affairs is at the leading edge of a trend. As the life sciences industry shifts towards precision medicine, its investment in medical and scientific affairs has steadily increased. From 2014 to 2016, MSL teams grew by 12% overall, and 31% in specialty areas such as oncology.

The success of these MSLs hinges on greater scientific insights, deeper collaboration, and a focus on tangible medical outcomes. Leading organisations are reinventing their medical affairs functions to meet the needs of this new era.

“In the life sciences industry, we see a shift toward transparency and collaboration,” says Robert Groebel, Vice President of Medical Strategy at Veeva Systems, the leader in cloud-based software for the global life sciences industry. “Medical affairs has a unique opportunity to add greater value to the journey.”

Medical affairs leaders from AstraZeneca, Bristol-Myers Squibb, Merck, Lilly, and other innovative life sciences organizations share their perspectives on key challenges impacting medical affairs and a roadmap for success in the coming decade in a new report: “Medical Affairs 2025”. Organisations will better understand how their peers address challenges today and how to transform medical affairs into a leading function within the company.  Access the full report here.

Comments

Nice to read about Medical Affairs 2025 and excellence in the era of precision medicine along with success of MSLs hinges on greater scientific insights, deeper collaboration, and a focus on tangible medical outcomes.

Alex,

http://www.qualityassignment.co.uk

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches